Optimizing Treatment in Low Myopes
-
By
-
Brooke M. Messer, OD, FSLS, FAAO
-
March 1, 2026
-
3 min
By
Brooke M. Messer, OD, FSLS, FAAO
March 1, 2026
Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia
May 8, 2026
Thomas Aller, OD, provides in-depth overviews of each myopia management option—pharmacologic therapy, soft contact lenses, orthokeratology, spectacle lenses, and environmental and behavioral interventions—so clinicians can not only provide the right option to each patient, but also address the larger economic and societal burdens of myopia.
May 1, 2026